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Spresenting with non-ST-segment acute coronary syndromes (NSTEACS) in the large-
scale ACUITY trial.
Methods: ACUITY was as an international randomized trial of different antith-
rombotic and antiplatelet regimens in 13,819 patients with moderate and high-risk
NSTEACS. Revascularization strategy was per discretion of the local clinical team.
We compared patients with a history of prior CABG by revascularization strategy
(CABG vs. PCI).
Results: A total of 1,433 NSTEACS patients with previous CABG underwent
revascularization in the ACUITY trial. Of them, 1,360 (94.9%) underwent PCI and 73
(5.1%) underwent redo CABG. Redo CABG was associated with greater rates of post-
procedural acute kidney injury (AKI) (30.0% vs. 10.8%, p<0.0001) and 30-day major
bleeding (63.1% vs. 6.6%, p<0.0001) compared with PCI. CABG (vs. PCI) was an
independent predictor of AKI and major bleeding. At 1-year, redo CABG rather than
PCI was associated with higher rates of MI (21.2%% vs. 13.5%, p¼0.04), mortality
(13.8% vs. 5.4%, p¼0.0007), and MACE (39.2% vs. 27.8%, p ¼0.007), whereas
ischemia-driven target vessel revascularization was more common in the PCI group
(12.4% vs. 1.7%, p¼0.02). By multivariable analysis, redo CABG was independently
associated with 1-year mortality and MACE (Table).
Conclusions: Patients with prior CABG presenting with NSTEACS who were
managed with redo CABG rather than PCI had higher rates of short- and long-term
adverse events. While not a randomized trial, these data suggest that PCI should be the
favored procedure in the NSTEACS patient with prior CABG in whom revasculari-
zation is required.Table. Independent Predictors of Events
Independent predictors of 1-year mortality
Male sex 3.38 [1.47, 7.76] 0.004
Acute kidney injury 2.96 [1.67, 5.26] 0.0002
CABG vs. PCI revascularization 2.94 [1.37, 6.25] 0.006
Diabetes 2.22 [1.30, 3.82] 0.004
Biomarker elevation 2.11 [1.21, 3.68] 0.009
Age (10-year increments) 1.79 [1.31, 2.45] 0.0002
Baseline hemoglobin 0.83 [0.71, 0.97] 0.02
Independent predictors of 1-year MACE
CABG vs. PCI revascularization 1.59 [1.03, 2.50] 0.04
Acute kidney injury 1.57 [1.15, 2.14] 0.004
Previous PCI 1.43 [1.13, 1.82] 0.003
Biomarker elevation 1.26 [1.00, 1.58] 0.046
AKI ¼ acute kidney injury; CABG ¼ coronary artery bypass graft; MACE ¼ major adverse
cardiovascular event; PCI ¼ percutaneous coronary intervention.TCT-232
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Background: Acute hyperglycemia on admission increases risk of cardiac events after
ST-elevated myocardial infarction(STEMI) patients. However, it still remains unclear
whether acute glycemic variability has the important prognostic signiﬁcance. There-
fore, this study aimed to evaluate the relationship between cardiac events and the
variability of glucose levels by a continuous glucose monitoring system (CGMS).
Methods: This prospective study enrolled 40 patients (age 7014 years, 78 % male)
with STEMI. All patients were inserted CGMS on admission and were measured at
least 48-hours. CGMS provide with glycemic excursion displayed at 5-minutes
intervals, 576 points during 48 hours. Primary end points were the incidence of major
adverse cardiac events (MACE) at 1 year, including cardiac death, myocardial
infarction, and heart failure.
Results: We found 3 patterns as the change of glucose wave (ﬁgure). The three
patterns were deﬁned persistent hyperglycemic pattern (PHP), intermittent hypergly-
cemic pattern (IHP), normal glycemic pattern (NGP). Signiﬁcant differences were
observed regarding the mean amplitude of glycemic excursions among 3 patterns
(12061mg/dl, 9341mg/dl, and 4516mg/dl in PHP, IHP, and NGP, respectively
p¼0.0004). The MACE incidence rates were 75%, 31%, and 5% in PHP, IHP, and
NGP, respectively, (p¼0.17).B76 JACC Vol 62/18/Suppl B j October 2Conclusions: A signiﬁcant relationship was observed between cardiac events and the
variability of hyperglycemic levels during 48 hours after coronary interventions.
Patients with PHP, even IHP, were associated with an increased risk of cardiac events.TCT-233
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Background: The purpose of this study was to evaluate the effects of statin treatment
in patients with ST-segment elevation myocardial infarction (STEMI) according to
completeness of revascularization.
Methods: From a total of 6657 STEMI patients who were registered in Korean Acute
Myocardial Infarction Registry from November 2005 to December 2007, 766 patients
were selected by subsequent propensity score matching (Age-, Sex-, LDL-cholesterol
level-, LVEF-) for 4 groups; complete revascularization with (CR+Statin, n¼199) or
without statin treatment (CR-Statin, n¼193) and incomplete revascularization with
(ICR+Statin, n¼178) or without statin treatment (ICR-Statin, n¼196). Major adverse
cardiac events (MACE) such as all-cause death, myocardial infarction (MI), target
vessel revascularization (TVR) were evaluated for 12 months.
Results: The rate of in-hospital mortality was not different among groups (3.0% in
CR+Statin vs. 5.7% in CR-Statin vs. 3.4% in ICR+Statin, 3.6% in ICR-Statin,
p¼0.520). During 12 months follow-up, MACE was developed in 15.5% of total
patients (10.1% of CR+Statin, 13.5% of CR-Statin, 15.2% of ICR+Statin and 23.5%
of ICR-Statin, p¼0.002). TVR (4.0% of CR+Statin vs. 5.2% of CR-Statin vs. 6.2% of
ICR+Statin, 16.3% of ICR-Statin, p<0.001) were signiﬁcantly different among groups
during 12 months follow-up. In subgroup analysis of patients with complete revas-
cularization, statin+ group has decreasing trend of MACE than statin- group, but not
signiﬁcantly (10.1% vs. 13.5%, p¼0.293). In case of patients with incomplete
revascularization, statin+ group has signiﬁcantly lower MACE than statin- group
(15.2% vs. 23.5%, p¼0.043).
Conclusions: The treatment of statin in patients with STEMI patients was considered
to improve clinical outcomes. Moreover, patients with incomplete revascularization of
STEMI performing primary PCI had more beneﬁcial effects of statin therapy than with
complete revascularization.7–November 1, 2013 j TCT Abstracts/POSTER/STEMI/NSTEMI/ACS
